Eton Pharmaceuticals Inc (ETON) recently announced its financial results for the quarter ended September 30, 2024, marking the 15th consecutive quarter of sequential product revenue growth. With a continued focus on managing profitability, the company is optimistic that 2025 will be a transformational year.
This commercial-stage company is developing and commercializing pharmaceutical products to address unmet needs in patients suffering from extremely rare conditions. It has 6 commercial products and 3 late-stage pipeline candidates.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.